BioLineRx (BLRX) Announces Presentation of Significant Safety, Efficacy Data for BL-8040
Tweet Send to a Friend
BioLineRx (NASDAQ: BLRX) announced the presentation of positive safety and efficacy results for its lead oncology candidate, BL-8040, as a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
